APA (7th ed.) Citation

Mae, H., Fujimaru, T., Shimoyama, K., Kadota, N., Konishi, K., Itou, Y., . . . Nakayama, M. (2024). Association of serum sodium minus chloride level at initiation of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and hyperkalemia in patients with CKD. Renal Replacement Therapy, 10(1), . https://doi.org/10.1186/s41100-024-00541-3

Chicago Style (17th ed.) Citation

Mae, Haruki, Takuya Fujimaru, Koutarou Shimoyama, Nozomi Kadota, Kasumi Konishi, Yugo Itou, Masahiko Nagahama, Fumika Taki, and Masaaki Nakayama. "Association of Serum Sodium Minus Chloride Level at Initiation of Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Hyperkalemia in Patients with CKD." Renal Replacement Therapy 10, no. 1 (2024). https://doi.org/10.1186/s41100-024-00541-3.

MLA (9th ed.) Citation

Mae, Haruki, et al. "Association of Serum Sodium Minus Chloride Level at Initiation of Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Hyperkalemia in Patients with CKD." Renal Replacement Therapy, vol. 10, no. 1, 2024, https://doi.org/10.1186/s41100-024-00541-3.